Bring Vaccines to Market Faster

Trusted Vaccine Industry Partner for Over 20 Years

3rd Annual mRNA Process Development & Manufacturing Summit
September 17-19, 2024
Boston, MA

Visit us at the booth!

Wednesday, September 18th at 12:30 pm ET

More samples and faster turnaround measuring capped mRNA integrity and 5’ capping efficiency

Randy Lacey, PhD
Field Application Scientist
InDevR

In this talk, you’ll learn about:

  • Rapidly measure intact, capped, and tailed mRNA in a single measurement to track mRNA integrity throughout the vaccine bioprocess.
  • Reduce down-time from outsourced LC/MS testing for 5’ capping efficiency by performing in-line assays.
  • Perform fit-for-purpose and in-process mRNA testing for all stages of vaccine development and mRNA manufacturing in under 2 hours without requiring extensive technical expertise.

Simplify 5′ Capping Measurements

Current vaccine manufacturers measure 5′ capping efficiency using complex chromatographic methods that can take 1-2 days with additional queue and analysis time. Reduce analytical turnaround times during mRNA vaccine development and measure 5′ capping efficiency in your laboratory with the 5’CapQ Assay.

  • Get Results Faster – Simplify testing with technology providing highly reproducible results in less than two hours.
  • Analysis at Your Benchtop – Reduce testing bottlenecks by bringing mRNA analytics to your facility.
  • Less Expertise Required – Standardize characterization of your mRNA vaccines on an easy-to-use microarray-based platform.

Maximize Efficiency in Vaccine Development with VaxArray

Discover the VaxArray Platform, your solution in multiplexed immunoassays designed to streamline vaccine development and analysis. This state-of-the-art system offers unparalleled precision and efficiency, empowering researchers to achieve faster, more reliable results in their efforts to advance public health.

  • Multiplex 50+ Analytes in Triplicate – VaxArray multiplexed technology outpaces traditional single-plex methods like ELISA in speed and efficiency.
  • Results in 1 Hour – Faster time to result compared to other technologies.
  • Versatile Platform – analyze a wide range of vaccine-relevant samples, from antibodies and antigens to nucleic acids.

Custom VaxArray for mRNA

Partner with InDevR for comprehensive mRNA customized solutions to simplify mRNA vaccine analytics and accelerate your path to market. InDevR’s Expert Services Team will create custom multiplexed assays to measure mRNA Critical Quality Attributes (CQA) in one platform.